---
title: hematopoietic stem cell transplantation
alias: HSCT
---

# hematopoietic stem cell transplantation

## [[stem cell]]

> Transplantation of donor pluripotent cells that can reconstitute all recipient blood lineages

- [[Stem Cell Transplant Basics]]
- [[mobility of hematopoietic stem cells]]
    - [[mobilization agent.md|mobilization agent]]
- [[hematopoietic stem cell microenvironment]]
- [[graft-versus-host disease]] GVHD
- [[donor-specific.md|donor-specific]]

---

> 類型、細胞來源、適應症、併發症、時機、預防

- [[categories of stem cell transplantation]]
    - [[autologous_stem_cell_transplantation.md|Autologous Stem Cell Transplantation]]
    - [[allogeneic_stem_cell_transplantation.md|allogeneic stem cell transplantation]]
- [[indications of hematopoietic stem cell transplantation]]
- [[transplantation procedure (for Allo HSCT)]]
- [[complications of hematopoietic stem cell transplantation]]
- [[timing of complications following allogeneic HSCT]]
- [[prophylaxis supportive medications during HSCT]]
- [[post-transplant_maintenance_therapy.md|Post-transplant maintenance therapy]]
- [[Transplant Infection Prevention, Overview]]
- [[2024-01-21-post-ash.md|2024-01-21-post-ASH]]

## Chronic Active Antibody-Mediated Rejection (ABMR)

- Diagnosis requires:
  - Morphologic evidence of chronic tissue injury (e.g. transplant glomerulopathy)
  - Evidence of current or recent antibody interaction with the vascular endothelium (e.g. linear C4d staining of peritubular capillaries)
  - Serologic evidence of donor-specific antibody (DSA) formation.
